1. Olijve, L.; Jennings, L.; Walls, T. Human Parechovirus: An Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants. Clin. Microbiol. Rev. 2018, 31. [CrossRef] [PubMed]
2. Chuchaona, W.; Khamrin, P.; Yodmeeklin, A.; Saikruang, W.; Kongsricharoern, T.; Ukarapol, N.; Okitsu, S.; Hayakawa, S.; Ushijima, H.; Maneekarn, N. Detection and characterization of a novel human parechovirus genotype in Thailand. Infect. Genet. Evol. 2015, 31, 300–304. [CrossRef] [PubMed]
3. Ito, M.; Yamashita, T.; Tsuzuki, H.; Takeda, N.; Sakae, K. Isolation and identification of a novel human parechovirus. J. Gen. Virol. 2004, 85. [CrossRef] [PubMed]
4. Fernandez-Garcia, M.D.; Simon-Loriere, E.; Kebe, O.; Sakuntabhai, A.; Ndiaye, K. Identification and molecular characterization of the first complete genome sequence of Human Parechovirus type 15. Sci. Rep. 2020, 10. [CrossRef]
5. de Crom, S.C.; Rossen, J.W.; van Furth, A.M.; Obihara, C.C. Enterovirus and parechovirus infection in children: A brief overview. Eur. J. Pediatr. 2016, 175, 1023–1029. [CrossRef]
6. Khatami, A.; McMullan, B.J.; Webber, M.; Stewart, P.; Francis, S.; Timmers, K.J.; Rodas, E.; Druce, J.; Mehta, B.; Sloggett, N.A.; et al. Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia. Clin. Infect. Dis. 2015, 60, 228–236. [CrossRef]
7. Karelehto, E.; van der Sanden, S.; Geraets, J.A.; Domanska, A.; van der Linden, L.; Hoogendoorn, D.; Koen, G.; van Eijk, H.; Shakeel, S.; Beaumont, T.; et al. Strain-dependent neutralization reveals antigenic variation of human parechovirus 3. Sci. Rep. 2017, 7, 12075. [CrossRef]
8. Selvarangan, R.; Nzabi, M.; Selvaraju, S.B.; Ketter, P.; Carpenter, C.; Harrison, C.J. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr. Infect. Dis. J. 2011, 30, 238–242. [CrossRef]
9. Boivin, G.; Abed, Y.; Boucher, F.D. Human parechovirus 3 and neonatal infections. Emerg. Infect. Dis. 2005, 11, 103–105. [CrossRef]
10. Levorson, R.E.; Jantausch, B.A.; Wiedermann, B.L.; Spiegel, H.M.; Campos, J.M. Human parechovirus-3 infection: Emerging pathogen in neonatal sepsis. Pediatr. Infect. Dis. J. 2009, 28, 545–547. [CrossRef]
11. Sano, K.; Hamada, H.; Hirose, S.; Sugiura, K.; Harada, S.; Koizumi, M.; Hara, M.; Nishijima, H.; Taira, M.; Ogura, A.; et al. Prevalence and characteristics of human parechovirus and enterovirus infection in febrile infants. Pediatr. Int. 2018, 60, 142–147. [CrossRef] [PubMed]
12. Harvala, H.; Calvert, J.; Van Nguyen, D.; Clasper, L.; Gadsby, N.; Molyneaux, P.; Templeton, K.; McWilliams Leitch, C.; Simmonds, P. Comparison of diagnostic clinical samples and environmental sampling for enterovirus and parechovirus surveillance in Scotland, 2010 to 2012. Euro. Surveill. 2014, 19. [CrossRef] [PubMed]
13. Britton, P.N.; Dale, R.C.; Nissen, M.D.; Crawford, N.; Elliott, E.; Macartney, K.; Khandaker, G.; Booy, R.; Jones, C.A.; Investigators, P.-A. Parechovirus Encephalitis and Neurodevelopmental Outcomes. Pediatrics 2016, 137, e20152848. [CrossRef] [PubMed]
14. Sedmak, G.; Nix, W.A.; Jentzen, J.; Haupt, T.E.; Davis, J.P.; Bhattacharyya, S.; Pallansch, M.A.; Oberste, M.S. Infant deaths associated with human parechovirus infection in Wisconsin. Clin. Infect. Dis. 2010, 50, 357–361. [CrossRef]
15. Verboon-Maciolek, M.A.; Groenendaal, F.; Hahn, C.D.; Hellmann, J.; van Loon, A.M.; Boivin, G.; de Vries, L.S. Human parechovirus causes encephalitis with white matter injury in neonates. Ann. Neurol. 2008, 64, 266–273. [CrossRef]
16. Vergnano, S.; Kadambari, S.; Whalley, K.; Menson, E.N.; Martinez-Alier, N.; Cooper, M.; Sanchez, E.; Heath, P.T.; Lyall, H. Characteristics and outcomes of human parechovirus infection in infants (2008–2012). Eur. J. Pediatr. 2015, 174, 919–924. [CrossRef]
17. Aizawa, Y.; Izumita, R.; Saitoh, A. Human parechovirus type 3 infection: An emerging infection in neonates and young infants. J. Infect. Chemother. 2017, 23, 419–426. [CrossRef]
18. Mizuta, K.; Yamakawa, T.; Kurokawa, K.; Chikaoka, S.; Shimizu, Y.; Itagaki, T.; Katsushima, F.; Katsushima, Y.; Ito, S.; Aoki, Y.; et al. Epidemic myalgia and myositis associated with human parechovirus type 3 infections occur not only in adults but also in children: Findings in Yamagata, Japan, 2014. Epidemiol. Infect. 2016, 144. [CrossRef]
19. Miyazaki, M.; Hara, K.; Takayoshi, T.; Kawase, T.; Nakagawa, Y.; Arai, T.; Sugimoto, T.; Nishiyama, K.; Gonzalez, G.; Hanaoka, N.; et al. Epidemic Myalgia Associated with Human Parechovirus Type 3 Infection. Intern. Med. 2020, 59. [CrossRef]
20. Romero, J.R.; Selvarangan, R. The human Parechoviruses: An overview. Adv. Pediatr. 2011, 58, 65–85. [CrossRef]
21. Mizuta, K.; Yamakawa, T.; Nagasawa, H.; Itagaki, T.; Katsushima, F.; Katsushima, Y.; Shimizu, Y.; Ito, S.; Aoki, Y.; Ikeda, T.; et al. Epidemic myalgia associated with human parechovirus type 3 infection among adults occurs during an outbreak among children: Findings from Yamagata, Japan, in 2011. J. Clin. Virol. 2013, 58, 188–193. [CrossRef] [PubMed]
22. Nakamura, K.; Saito, K.; Hara, Y.; Aoyagi, T.; Kitakawa, K.; Abe, Y.; Takemura, H.; Ikeda, F.; Kaku, M.; Kanemitsu, K. Severe epidemic myalgia with an elevated level of serum interleukin-6 caused by human parechovirus type 3: A case report and brief review of the literature. BMC Infect. Dis. 2018, 18, 381. [CrossRef]
23. van der Sanden, S.M.; Koopmans, M.P.; van der Avoort, H.G. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996–2011. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32, 1525–1531. [CrossRef]
24. Domanska, A.; Flatt, J.W.; Jukonen, J.J.J.; Geraets, J.A.; Butcher, S.J. A 2.8-Angstrom-Resolution Cryo-Electron Microscopy Structure of Human Parechovirus 3 in Complex with Fab from a Neutralizing Antibody. J. Virol. 2019, 93. [CrossRef] [PubMed]
25. Shakeel, S.; Westerhuis, B.M.; Domanska, A.; Koning, R.I.; Matadeen, R.; Koster, A.J.; Bakker, A.Q.; Beaumont, T.; Wolthers, K.C.; Butcher, S.J. Multiple capsid-stabilizing interactions revealed in a high-resolution structure of an emerging picornavirus causing neonatal sepsis. Nat. Commun. 2016, 7, 11387. [CrossRef] [PubMed]
26. Shakeel, S.; Dykeman, E.C.; White, S.J.; Ora, A.; Cockburn, J.J.B.; Butcher, S.J.; Stockley, P.G.; Twarock, R. Genomic RNA folding mediates assembly of human parechovirus. Nat. Commun. 2017, 8, 5. [CrossRef]
27. Chen, B.C.; Chang, J.T.; Huang, T.S.; Chen, J.J.; Chen, Y.S.; Jan, M.W.; Chang, T.H. Parechovirus A Detection by a Comprehensive Approach in a Clinical Laboratory. Viruses 2018, 10, 711. [CrossRef]
28. Abed, Y.; Wolf, D.; Dagan, R.; Boivin, G. Development of a serological assay based on a synthetic peptide selected from the VP0 capsid protein for detection of human parechoviruses. J. Clin. Microbiol. 2007, 45. [CrossRef]
29. Yamaoka, Y.; Matsuyama, S.; Fukushi, S.; Matsunaga, S.; Matsushima, Y.; Kuroyama, H.; Kimura, H.; Takeda, M.; Chimuro, T.; Ryo, A. Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen. Front. Microbiol. 2016, 7, 509. [CrossRef]
30. Khatun, H.; Yamaoka, Y.; Matsushima, Y.; Matsunaga, S.; Kimura, H.; Ho, J.; Shuda, M.; Ryo, A. Production and characterization of monoclonal antibodies specific for major capsid VP1 protein of trichodysplasia spinulosa-associated polyomavirus. Microbiol. Immunol. 2018, 62, 763–773. [CrossRef]
31. Wildenbeest, J.G.; Benschop, K.S.; Minnaar, R.P.; Bouma-de Jongh, S.; Wolthers, K.C.; Pajkrt, D. Clinical relevance of positive human parechovirus type 1 and 3 PCR in stool samples. Clin. Microbiol. Infect. 2014, 20, O640–O647. [CrossRef] [PubMed]
32. Kadambari, S.; Harvala, H.; Simmonds, P.; Pollard, A.J.; Sadarangani, M. Strategies to improve detection and management of human parechovirus infection in young infants. Lancet Infect. Dis. 2019, 19, e51–e58. [CrossRef]
33. Matsunaga, S.; Kawakami, S.; Matsuo, I.; Okayama, A.; Tsukagoshi, H.; Kudoh, A.; Matsushima, Y.; Shimizu, H.; Okabe, N.; Hirano, H.; et al. Wheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibody. Front. Microbiol. 2014, 5, 208. [CrossRef] [PubMed]
34. Nelson, P.N.; Reynolds, G.M.; Waldron, E.E.; Ward, E.; Giannopoulos, K.; Murray, P.G. Monoclonal antibodies. Mol. Pathol. 2000, 53, 111–117. [CrossRef] [PubMed]
35. Sirivichayakul, C.; Limkittikul, K.; Chanthavanich, P.; Yoksan, S.; Ratchatatat, A.; Lim, J.K.; Arunsodsai, W.; Sabchareon, A. Monoclonal antibody-based capture ELISA in the diagnosis of previous dengue infection. Virol. J. 2019, 16, 125. [CrossRef] [PubMed]
36. Pikora, C.; Wittish, C.; Desrosiers, R.C. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4. J. Virol. 2005, 79, 12575–12583. [CrossRef]
37. Stove, V.; Ramos, P.A.; Wallemacq, P.; Vogeser, M.; Schuetzenmeister, A.; Schmiedel, C.; Shipkova, M. Measurement of sirolimus concentrations in human blood using an automated electrochemiluminescence immunoassay (ECLIA): A multicenter evaluation. Clin. Chem. Lab. Med. 2018, 56, 764–775. [CrossRef]
38. Wada, A.; Sakoda, Y.; Oyamada, T.; Kida, H. Development of a highly sensitive immunochromatographic detection kit for H5 influenza virus hemagglutinin using silver amplification. J. Virol. Methods 2011, 178, 82–86. [CrossRef]
39. Mishra, M.; Tiwari, S.; Gunaseelan, A.; Li, D.; Hammock, B.D.; Gomes, A.V. Improving the sensitivity of traditional Western blotting via Streptavidin containing Poly-horseradish peroxidase (PolyHRP). Electrophoresis 2019, 40, 1731–1739. [CrossRef]